Navigation Links
Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
Date:11/12/2012

INDIANAPOLIS, Nov. 12, 2012 /PRNewswire/ -- Roche Diagnostics, a world leader in pharmaceuticals and diagnostics, announced in June its plans to invest $300 million during the next 10 years in expanding its North American headquarters located on the northeast side of Indianapolis.  The first phase of the project is a new Learning and Development Center, where approximately 1,500 customers from across the nation will be trained each year. 

Mayor Greg Ballard will be joined by Roche Diagnostics President and CEO Jack Phillips along with members of the City-County Council and community leaders to break ground on the expansion and unveil renderings of the new building, which will have a distinct architectural style.  WHO: Mayor Greg BallardJack Phillips, President and CEO, Roche DiagnosticsMembers of City-County CouncilWHEN:Wednesday, November 14, 201210:00 A.M. Eastern Standard TimeWHAT:Groundbreaking Ceremony for Roche Diagnostics Learning and Development CenterWHERE:Roche Diagnostics Campus – Near Entrance 49115 Hague Road, Indianapolis, IndianaRSVP:Please RSVP to Jacque Robertson at jacque.robertson@roche.com or (317) 521-2819Due to limited parking on corporate campus, RSVPs are appreciated.NOTE:Press riser with mult box to be provided.  Principals will be made available to press following event. About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Director, Corporate Communications

Roche Diagnostics

Indianapolis, IN(317) 521-3966 O

(317) 361-7637 Ctodd.siesky@roche.com

  


'/>"/>
SOURCE Roche Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New York City Mayor Bloomberg and Health Commissioner Farley Receive Flu Shot at Duane Reade Pharmacy, Highlight Importance of Flu Preparedness
2. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
3. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
4. Roche cytomegalovirus viral load test now available in US
5. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
6. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
7. Rochester Medical Reports Third Quarter Results
8. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
9. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
10. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
11. Roche announces FDA approval of HIV viral load test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... MENLO PARK, Calif. , Oct. 11, 2017 /PRNewswire/ ... a national scientific team that developed an innovative way ... and quantity of the delivery of new drugs. ... the 2017 Fall Clinical Dermatology Conference will show how ... Massachusetts General Hospital, Harvard Medical School used a suite ...
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):